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The lean and fat masses, bone mineral density (BMD) were mea-
sured by the DXA method (Prodigy, GEHC Lunar, Madison, WI, 
USA). Appendicular skeletal mass (ASM) was measured at all the 
four limbs with DXA. We’ve also calculated the appendicular skel-
etal mass index (ASMI) according to the formula: ASM/height 
(kg/m2).
Results: We observed a significant decrease of ASM with age (20-
29 yrs – 16.5 ± 0.4 kg, 30-39 yrs – 16.4 ± 0.3 kg, 40-49 yrs – 17.0 ± 
0.5 kg, 50-59 yrs – 16.9 ± 0.3 kg; 60-69 yrs – 16.5 ± 0.2; 70-79 yrs 
–15.8 ± 0.3; 80-87 yrs – 15.3 ± 0.3; F = 2.7; p = 0.01). The ASMI values 
corresponding to a cutoff of low muscle mass by the definitions used 
were as follows: < 5.5 kg/m2 (European guideline), < 5.7 kg/m2 
(< 20th percentile of sex specific population), < 4.8 kg/m2 (two SD be-
low the mean of young Ukrainian females aged 20-39 yrs). The prev-
alence of low muscle mass in women aged 65 yrs and older based on 
the above three criteria was 12%, 16% and 1.7%, respectively. ASM 
was positively correlated with total fat mass (r = 0.20, p = 0.0006) and 
BMD at all sites (BMD of spine (r = 0.22, p = 0.0002), BMD of femoral 
neck (r = 0.29, p < 0.0001)).
Conclusions: The cutoff value of ASMI (< 4.8 kg/m2) was lower in 
our study compared with Rosetta Study (< 5.5 kg/m2) and similar to 
Health ABC study (< 5.67 kg/m2).
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Introduction: Osteoporosis is one of the common diseases 
which can lead to increasing of morbidity and mortality. The met-
abolic syndrome (MS), which includes obesity, dyslipidemia, im-
paired glucose tolerance, hypertension, is a major public health 
problem also. Traditionally, there is a mind that obesity is protec-
tive against osteoporosis but other components of MS are risk fac-
tors of it.
Objectives: To determine the frequency of low bone mineral den-
sity (BMD) in women with MS and obesity alone.
Methods: The study involved 1,605 40-79 years old postmeno-
pausal women. Patients were compared into three groups. First 
group included women without obesity (800 people), second group 
involved patients with obesity (572 people). MS was diagnosed in 
women of the third group (233 people). BMD was measured by du-
al-energy X-ray absortiometry (Prodigy, 2005 yr.). Women were con-
sidered to have normal or low BMD according to criteria of the 
Official Positions of the ISCD, 2007 yr. Data were analyzed using 
Statistical Package 6.0.
Results: Positive association of the BMD indexes and weight in 
all groups of the examined was revealed. This can indicate the pro-
tective effect of obesity on bone tissue. It was found that frequency 
of the low BMD at the lumber region is higher in the first group 
women than in patients of the second and third groups (70.08%, 
39.98% and 42.49% respectively). The worse situation was shown at 
the region of the femoral neck. The low BMD was presented in 
78.05% of the first group women, 59.79% of the second group pa-
tients and 57.93% of the third group people. This can suggest the 
opinion that spongy bone tissue is prominently damaging in post-
menopausal women.
Conclusions: Our study estimated that osteoporosis and low 
BMD are significantly much rarer in women with obesity and MS 
compared to those without obesity.
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Introduction: Despite in type 2 diabetes mellitus (T2DM) the 
bone mineral density is usually normal, an increased fracture rate 
has been described.
Objectives: To evaluate the influence of T2DM in the bone min-
eral density (BMD) and in the trabecular bone score (TBS) in post-
menopausal women.
Methods: Transversal controlled study of 173 post-menopausal 
women, of the metabolic bone diseases out-patient clinic; they were 
divided in the T2DM and control groups, matched for age, BMI and 
post-menopause duration. BMD was measured by DXA at L1-L4 and 
at the femoral neck; TBS was derived from each DXA scan at the 
lumbar spine. Fasting blood samples were collected for hormonal 
and biochemical parameters including calcium metabolism. The 
adequate statistical analysis tests were performed (significance: 
p < 0.05).
Results: The mean post-menopause duration [18.2 (± 11.0) vs 18.3 
(± 9.7) years], weight [77.0 (± 13.3) vs 77.17 (± 10.7) kg/m2] were sim-
ilar between the groups. In the T2DM group the mean BMD at the 
lumbar spine and at the femoral neck were significantly increased, 
as compared to the control group. Nevertheless, the mean TBS was 
similar between the groups. Significant correlations between age vs 
25(OH)D blood concentrations (r = -0.34), vs BMD at the femoral neck 
(r = -0.46) and vs BMD at the lumbar spine (r = -0.34) were found in 
the T2DM group, but not in the control group. The TBS correlated 
positively with 25(OH)D blood levels only in T2DM.
Conclusions: This study shows that T2DM postmenopausal 
women the mean BMD at the proximal femur and at the lumbar 
spine are increased, while the mean TBS is identical, as compared 
with the control group. The 25(OH)D levels seem to affect positively 
BMD and bone quality evaluated by TBS only T2DM women.
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Introduction: The assessment and qualification of the bone mi-
croarchitecture can be indirectly evaluated by the trabecular bone 
score (TBS) or bone quality. TBS is a non-invasive tool that can ex-
plore other factors than BMD that may inﬂuence bone strength and 
fracture risk, such as trabecular density connections and trabeculae 
separations. Nevertheless, the impact of anthropometric, insulin re-
sistance parameters and 25(OH)D blood levels on TBS remain to be 
clarified in men.
Objectives: To investigate the contributions of weight, body mass 
index (BMI), total body fat mass, blood insulin concentration and 
homeostasis model assessment (HOMA) to TBS and vitamin D in a 
group of men.
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Methods: BMD at the lumbar spine (g/cm2) and at the whole-body 
were accessed by dual-energy X-ray absorptiometry scans (Discov-
ery-W densitometer, Hologic,Inc.) and TBS (obtained from L1-L4 DXA 
images) were evaluated in a group of 63 normal men aged ≥ 40 years 
[mean (± SD) = 55.0 (± 12.3) years]. Fasting blood collections were 
performed for measurements of the glucose, insulin and 25(OH)D 
(ng/ml) levels. Insulin resistance was calculated by HOMA. Adequate 
statistical tests were used (statistical significance for p < 0.05).
Results: The effects of anthropometric and biochemical parame-
ters on TBS are shown in the table.
The correlation analysis between TBS and anthropometric, insulin, insulin 
 resistance (HOMA-IR) and 25(OH)D parameters
Parameter TBS p
Weight Kg -0.6281 0.0000
BMI Kg/m2 -0.7005 0.0000
Total body fat mass kg -0.6511 0.0000
Fat mass% -0.5507 0.0000
IRI mcUI/ml -0.4412 0.0009
HOMA-IR -0.4989 0.0000
25(OH)D ng/ml 0.3001 0.0169
Conclusions: The results of this study support the hypothesis that 
weight, total body fat mass, insulin and insulin resistance are inversely 
associated with TBS values and play a direct role in bone metabolism. 
Moreover, these data suggest that blood vitamin D concentrations 
may have an important role on the bone quality accessed by TBS.
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Introdução: A suplementação de cálcio no adulto nas doses reco-
mendadas (1-1,2 g) continua a gerar controvérsia por questões de 
segurança.
Objectivos: Por forma a contornar os riscos associados a esta su-
plementação, estudou-se o efeito de um suplemento com uma dose 
inferior cálcio (420 mg) associado a uma fibra solúvel (goma Guar na 
dose de 450 mg/dia) na prevenção das alterações ósseas associadas à 
deficiência em estrogénio bem como a sua segurança.
Métodos: Ratos Wistar fêmeas (n = 18) aleatorizados em 3 grupos: 
sham, ovariectomizados (OVX), ovariectomizados-suplementados 
(OVX+S) com concha ostra (105 mg/kg) e goma Guar (43 mg/kg) 
por 53-dias (dose equivalente humana de 420 mg/dia cálcio e 
414,5 mg/dia Guar). No dia 60 avaliou-se: peso corporal, depósitos de 
cálcio na aorta, fígado e rim (coloração Von Kossa), cálcio femoral e 
urinário (absorção atómica), biomecânica do fémur, ultra-estrutura 
do osso cortical da tíbia (SEM) e biomarcadores da remodelação ós-
sea. Aplicou-se o teste de Kruskal-Wallis no tratamento dos dados 
(p < 0,05).
Resultados: O peso corporal dos animais suplementados e não su-
plementados aumentou 22 e 33% respectivamente. Os exames histo-
lógicos não revelaram depósitos de cálcio. A remodelação óssea 
aumentou (p < 0,05) nos OVX e OVX+S. A calciuria aumentou nos OVX 
(p < 0,05) e OVX+S. O suplemento mitigou a hipocalcemia (p < 0,01), a 
redução do cálcio femoral (p < 0,05) e a redução da espessura do osso 
cortical da tíbia enquanto a rigidez e a tensão máxima de fractura do 
osso femoral aumentaram (p < 0,05) quando comparada ao dos OVX.
Conclusões: A suplementação com baixas doses de cálcio de con-
cha de ostras e goma Guar atenuou o ganho de peso corporal, a cal-
ciuria, a hipocalcemia e a redução da espessura do osso cortical da 
tibia bem como a desmineralização do osso femoral tornando-o mais 
rígido e resistente à fractura sem risco aparente de depósitos vascu-
lares renais e hepáticos de cálcio.
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Introduction: Osteoporosis (OP) is a disease with increasing 
prevalence due to increased life expectancy. It presents high morbid-
ity and mortality by fractures associated with it.
Objectives: Characterization of the population of patients sent for 
the first time to Fracturary osteoporosis outpatient clinic, HSM-
CHLN between 1.01 and 30/10/2015.
Methods: Data collection: 1) of the patients sent to this outpatient 
clinic, 2) demographic and clinical factors associated with risk fac-
tors for OP. The data were submitted to appropriate statistical anal-
ysis and significance was set at p < 0.05.
Results: Of the 101 patients included 91 (90.1%) were women. The 
average age was 75.7 (± 9.5) years. The average age of menopause was 
48.9 (± 4.3) years. 5 patients (6.1%) done hormone therapy (HT). 7 pa-
tients (7.9%) had a family history of fractures of the proximal femur. 
58.4% of patients had hypertension, 18.8% type 2 DM and 10,1% CRF. 
93 patients were not addressed any medication, 5 patients were bi-
sphosphonates, strontium ranelate 1 and 2 supplementation with 
calcium and vitamin D. 19 patients performed therapy with proton 
pump inhibitors, 7 recently prolonged corticotherapy and 4 therapy 
with GnRH analogues. 95 patients had never done a DXA.
Conclusions: 10% of men found in this study counteracts the ste-
reotype that OP is an exclusive disease of women. The average age of 
menopause was within the normal range. In addition, it should be 
considered other parameters. TH, family history, comorbidity and 
existence of concomitant therapies. Early recognition of the OP al-
lows the establishment of measures with the aim of reducing the 
prevalence of fractures and its complications. We consider it essen-
tial to integrated approach of this multidisciplinary approach.
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Introduction: Parkinson’s disease (PD) and osteoporosis are 
chronic diseases associated with aging. Several studies have re-
ported associations between these two entities, particularly regard-
ing to increased risk of fractures.
Objectives: Review the existing evidence about the relationship 
between PD and osteoporosis. Review the pathophysiological mech-
anisms involved.
